Steven Cohen’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
Steven Cohen's ELDN Position: Q3 2026 in Review
Steven Cohen opened a new position in Eledon Pharmaceuticals (ELDN) in Q3 2026: 53,247 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3592 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ELDN as recently as Q4 2024.
Steven Cohen first reported a position in ELDN in Q1 2021 and has held it in 9 quarters since. The position peaked at $4.51M in Q4 2024. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- Steven Cohen held 53,247 shares of Eledon Pharmaceuticals worth $135K as of Q3 2026.
- Eledon Pharmaceuticals was a new Steven Cohen position in Q3 2026.
- Eledon Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3592 holding.
- Steven Cohen first reported a position in Eledon Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
- Steven Cohen's Eledon Pharmaceuticals position peaked at $4.51M in Q4 2024.
- 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.